Technology-enabled Management Versus Usual Care for Blood Pressure

Recruiting now · Not applicable

Conditions studied: Hypertension

In brief

Two arm parallel randomized clinical trial

Key facts

Study ID

NCT05479461

Run by

Stanford University

People needed

200

Starts

2023-06-13

Expected to finish

2025-09-15

Last updated by the study team

2025-08-11

Who can join

Age: 30 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 30-90 yrs.
• Smartphone ownership
• Office SBP: ≥ 140 mm Hg
• ≤ 2 current anti-HTN meds
• Able to add or dose-increase at least 2 of the following classes of medications: ACE-I/ARB, diuretic, calcium channel blocker, beta-blocker, mineralocorticoid receptor antagonists (i.e., at least 2 classes are available for addition or dose- increases after excluding intolerant medications and medications currently at maximum dose)
• English or Spanish-speakers

You may not qualify if…

• Heart failure with reduced ejection fraction (EF < 40%)
• ESRD (GFR <15)
• Renal replacement therapy
• Pregnant
• Myocardial infarction or stroke within preceding 6 months
• Hospitalization for hypertensive emergency or malignant hypertension within preceding 6 months
• Prior solid organ transplantation
• At the clinical discretion of the investigators
• Enrolled in another clinical study

Where it is running

• Stanford Health Care — Palo Alto, California, United States (enrolling)
• Morehouse School of Medicine — Atlanta, Georgia, United States (enrolling)
• Lake Country Medical Group — Eatonton, Georgia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.